BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8218861)

  • 1. A novel point mutation (Val 297-->Met) in the serine proteinase domain of protein C in a patient with both venous and arterial thromboembolic disease.
    Millar DS; Wacey AI; Voke J; Kakkar VV; Cooper DN
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):631-3. PubMed ID: 8218861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular model of a point mutation (Val297Met) in the serine protease domain of protein C.
    Song KS; Park YS; Choi JR; Kim HK; Park Q
    Exp Mol Med; 1999 Mar; 31(1):47-51. PubMed ID: 10231023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular model of the serine protease domain of activated protein C: application to the study of missense mutations causing protein C deficiency.
    Wacey AI; Pemberton S; Cooper DN; Kakkar VV; Tuddenham EG
    Br J Haematol; 1993 Jun; 84(2):290-300. PubMed ID: 8398833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible structural implications of 20 mutations in the protein C protease domain.
    Greengard JS; Griffin JH; Fisher CL
    Thromb Haemost; 1994 Dec; 72(6):869-73. PubMed ID: 7740456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: patterns revealed by three-dimensional molecular modelling of mutations of the protease domain.
    Greengard JS; Fisher CL; Villoutreix B; Griffin JH
    Proteins; 1994 Apr; 18(4):367-80. PubMed ID: 8208728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six different point mutations in seven Danish families with symptomatic protein C deficiency.
    Lind B; Schwartz M; Thorsen S
    Thromb Haemost; 1995 Feb; 73(2):186-93. PubMed ID: 7792728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous protein C deficiency: identification of a novel missense mutation that causes impaired secretion of the mutant protein C.
    Yamamoto K; Matsushita T; Sugiura I; Takamatsu J; Iwasaki E; Wada H; Deguchi K; Shirakawa S; Saito H
    J Lab Clin Med; 1992 Jun; 119(6):682-9. PubMed ID: 1593215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for protein C hereditary deficiency.
    Aiach M; Gandrille S
    Haemostasis; 1996 Oct; 26 Suppl 4():9-19. PubMed ID: 8979107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular basis for protein C deficiency caused by a single amino acid substitution at Arg15 in the gamma-carboxyglutamic acid domain.
    Tokunaga F; Tsukamoto T; Koide T
    J Biochem; 1996 Aug; 120(2):360-8. PubMed ID: 8889822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three missense mutations in the protein C heavy chain causing type I and type II protein C deficiency.
    Miyata T; Zheng YZ; Sakata T; Tsushima N; Kato H
    Thromb Haemost; 1994 Jan; 71(1):32-7. PubMed ID: 8165644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C Sapporo (protein C Glu 25 --> Lys): a heterozygous missense mutation in the Gla domain provides new insight into the interaction between protein C and endothelial protein C receptor.
    Nakabayashi T; Mizukami K; Naitoh S; Takeda M; Shikamoto Y; Nakagawa T; Kaneko H; Tarumi T; Mizoguchi I; Mizuno H; Ieko M; Koike T
    Thromb Haemost; 2005 Nov; 94(5):942-50. PubMed ID: 16363234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic type 1 protein C deficiency caused by a de novo Ser270Leu mutation in the catalytic domain.
    Lind B; Koefoed P; Thorsen S
    Br J Haematol; 2001 Jun; 113(3):642-8. PubMed ID: 11380450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein C deficiency and thromboembolism: recurrent mutation at Arg 306 in the protein C gene.
    Grundy CB; Schulman S; Krawczak M; Kobosko J; Kakkar VV; Cooper DN
    Hum Genet; 1992 Mar; 88(5):586-8. PubMed ID: 1348046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein C Osaka 10 with aberrant propeptide processing: loss of anticoagulant activity due to an amino acid substitution in the protein C precursor.
    Miyata T; Zheng YZ; Sakata T; Kato H
    Thromb Haemost; 1995 Oct; 74(4):1003-8. PubMed ID: 8560401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel homozygous missense mutation (Val 325-->Ala) in the protein C gene causing neonatal purpura fulminans.
    Witt I; Beck S; Seydewitz HH; Tasangil C; Schenck W
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):651-3. PubMed ID: 7841324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of protein C: a comparative review of antigenic and functional assays.
    Marlar RA; Adcock DM
    Hum Pathol; 1989 Nov; 20(11):1040-7. PubMed ID: 2680891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular anomalies of coagulation inhibitors].
    Aiach M
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):265-6. PubMed ID: 8337141
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel nonsense mutation in the protein C (PROC) gene (Trp-29-->term) causing recurrent venous thrombosis.
    Millar DS; Grundy CB; Bignell P; Mitchell DC; Corden D; Woods P; Kakkar VV; Cooper DN
    Hum Genet; 1993 Mar; 91(2):196. PubMed ID: 8462980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.
    Voorberg J; Roelse J; Koopman R; Büller H; Berends F; ten Cate JW; Mertens K; van Mourik JA
    Lancet; 1994 Jun; 343(8912):1535-6. PubMed ID: 7911872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The conserved methionine residue of the metzincins: a site-directed mutagenesis study.
    Hege T; Baumann U
    J Mol Biol; 2001 Nov; 314(2):181-6. PubMed ID: 11718552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.